New locus for autosomal dominant mitral valve prolapse on chromosome 13: Clinical insights from genetic studies

Circulation

Volumn 112, Issue 13, 2005, Pages 2022-2030

  Nesta, Francesca ^a   Leyne, Maire ^a   Yosefy, Chaim ^a   Simpson, Charles ^a   Dai, Daisy ^a   Marshall, Jane E ^a   Hung, Judy ^a   Slaugenhaupt, Susan A ^a   Levine, Robert A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Echocardiography; Genetics; Mitral valve

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHROMOSOME 13; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ENDOCARDITIS; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE LOCUS; GENE SEGREGATION; GENETIC DISORDER; GENETIC MARKER; HAPLOTYPE; HEART FAILURE; HUMAN; MALE; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; MMVP3 GENE; PARAMETRIC TEST; PRIORITY JOURNAL; SCHOOL CHILD; SUDDEN DEATH;

ADULT; AGED; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 13; ECHOCARDIOGRAPHY; FEMALE; GENES, DOMINANT; GENETIC HETEROGENEITY; HUMANS; LINKAGE (GENETICS); LOD SCORE; MALE; MIDDLE AGED; MITRAL VALVE PROLAPSE; PEDIGREE;

EID: 25444451002     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.516930     Document Type: Article

References (57)

1. Freed LA, Benjamin EJ, Levy D, Larson MG, Evans JC, Fuller DL, Lehman B, Levine RA. Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart Study. J Am Coll Cardiol. 2002;40:1298-1304.
2. Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL, Lehman B, Benjamin EJ. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med. 1999;341:1-7.
3. Tamura K, Fukuda Y, Ishizaki M, Masuda Y, Yamanaka N, Ferrans VJ. Abnormalities in elastic fibers and other connective-tissue components of floppy mitral valve. Am Heart J. 1995;129:1149-1158.
4. Rabkin E, Aikawa M, Stone JR, Fukumoto Y, Libby P, Schoen FJ. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation. 2001;104:2525-2532.
5. Devereux RB, Kramer-Fox R, Shear MK, Kligfield P, Pini R, Savage DD. Diagnosis and classification of seventy of mitral valve prolapse: methodologic, biologic, and prognostic considerations. Am Heart J. 1987;113: 1265-1280.
6. Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia, Pa: WB Saunders Co; 1992.
7. Avierinos JF, Gersh BJ, Melton LJ 3rd, Bailey KR, Shub C, Nishimura RA, Tajik AJ, Enriquez-Sarano M. Natural history of asymptomatic mitral valve prolapse in the community. Circulation. 2002;106: 1355-1361.
8. Perloff JK, Child JS. Clinical and epidemiologic issues in mitral valve prolapse: overview and perspective. Am Heart J. 1987;113:1324-1332.
9. Waller BF, Morrow AG, Maron BJ, Del Negro AA, Kent KM, McGrath FJ, Wallace RB, McIntosh CL, Roberts WC. Etiology of clinically isolated, severe, chronic, pure mitral regurgitation: analysis of 97 patients over 30 years of age having mitral valve replacement. Am Heart J. 1982;104:276-288.
10. Devereux RB, Brown WT, Kramer-Fox R, Sachs I. Inheritance of mitral valve prolapse: effect of age and sex on gene expression. Ann Intern Med. 1982;97:826-832.
11. Strahan NV, Murphy EA, Fortuin NJ, Come PC, Humphries JO. Inheritance of the mitral valve prolapse syndrome: discussion of a three-dimensional penetrance model. Am J Med. 1983;74:967-972.
12. Glesby MJ, Pyeritz RE. Association of mitral valve prolapse and systemic abnormalities of connective tissue: a phenotypic continuum. JAMA. 1989; 262:523-528.
13. Roman MJ, Devereux RB, Kramer-Fox R, Spitzer MC. Comparison of cardiovascular and skeletal features of primary mitral valve prolapse and Marfan syndrome. Am J Cardiol. 1989;63:317-321.
14. Henney AM, Tsipouras P, Schwartz RC, Child AH, Devereux RB, Leech GJ. Genetic evidence that mutations in the COL1A1, COL1A2, COL3A1, or COL5A2 collagen genes are not responsible for mitral valve prolapse. Br Heart J. 1989;61:292-299.
15. Wordsworth P, Ogilvie D, Akhras F, Jackson G, Sykes B. Genetic segregation analysis of familial mitral valve prolapse shows no linkage to fibrillar collagen genes. Br Heart J. 1989;61:300-306.
16. Levine RA, Triulzi MO, Harrigan P, Weyman AE. The relationship of mitral annular shape to the diagnosis of mitral valve prolapse. Circulation. 1987;75:756-767.
17. Levine RA, Stathogiannis E, Newell JB, Harrigan P, Weyman AE. Reconsideration of echocardiographic standards for mitral valve prolapse: lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormality. J Am Coll Cardiol. 1988;11:1010-1019.
18. Levine RA, Handschumacher MD, Sanfilippo AJ, Hagege AA, Harrigan P, Marshall JE, Weyman AE. Three-dimensional echocardiographic reconstruction of the mitral valve, with implications for the diagnosis of mitral valve prolapse. Circulation. 1989;80:589-598.
19. Perloff JK, Child JS. Mitral valve prolapse: evolution and refinement of diagnostic techniques. Circulation. 1989;80:710-711.
20. Nidorf SM, Weyman AE, Hennessey R, Newell JB, Levine AB. The relationship between mitral valve morphology and prognosis in patients with mitral valve prolapse: a prospective echocardiographic study of 568 patients. J Am Soc Echocardiogr. 1993;6:S8. Abstract.
21. Disse S, Abergel E, Berrebi A, Houot AM, Le Heuzey JY, Diebold B, Guize L, Carpentier A, Corvol P, Jeunemaitre X. Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet. 1999;65:1242-1251.
22. Freed LA, Acierno JS Jr, Dai D, Leyne M, Marshall JE, Nesta F, Levine RA, Slaugenhaupt SA. A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet. 2003;72: 1551-1559.
23. Kyndt F, Schott JJ, Trochu JN, Baranger F, Herbert O, Scott V, Fressinaud E, David A, Moisan JP, Bouhour JB, Le Marec H, Benichou B. Mapping of X-linked myxomatous valvular dystrophy to chromosome Xq28. Am J Hum Genet. 1998;62:627-632.
24. Solomon SD, Jarcho JA, McKenna W, Geisterfer-Lowrance A, Germain R, Salerni R, Seidman JG, Seidman CE. Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease. J Clin Invest. 1990;86: 993-999.
25. Maron BJ, Moller JH, Seidman CE, Vincent GM, Dietz HC, Moss AJ, Towbin JA, Sondheimer HM, Pyeritz RE, McGee G, Epstein AE. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome: a statement for healthcare professionals from the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association. Circulation. 1998;98:1460-1471.
26. Marks AR, Choong CY, Sanfilippo AJ, Ferre M, Weyman AE. Identification of high-risk and low-risk subgroups of patients with mitral-valve prolapse. N Engl J Med. 1989;320:1031-1036.
27. Zuppiroli A, Roman MJ, O'Grady M, Devereux RB. A family study of anterior mitral leaflet thickness and mitral valve prolapse. Am J Cardiol. 1998;82:823-826, A10.
28. Shah PM. Echocardiographic diagnosis of mitral valve prolapse. J Am Soc Echocardiogr. 1994;7:286-293.
29. Weissman NJ, Pini R, Roman MJ, Kramer-Fox R, Andersen HS, Devereux RB. In vivo mitral valve morphology and motion in mitral valve prolapse. Am J Cardiol. 1994;73:1080-1088.
30. Nishimura RA, McGoon MD, Shub C, Miller FA Jr, Ilstrup DM, Tajik AJ. Echocardiographically documented mitral-valve prolapse: long-term follow-up of 237 patients. N Engl J Med. 1985;313:1305-1309.
31. Vivaldi MT, Sagie A, Adams MS, Levine RA. 10-Year echocardiographic and clinical follow-up of patients with nonclassic mitral valve prolapse: does it progress? Circulation. 1994;90(suppl I):I-222. Abstract.
32. Nesta F, Freed L, Leyne M, Marshall J, Slagenhaupt S, Levine R. Coaptation height: a new marker of mitral leaflet redundancy. J Am Soc Echocardiogr. 2003;16:538. Abstract.
33. Ott J. Computer-simulation methods in human linkage analysis. Proc Natl Acad Sci U S A. 1989;86:4175-4178.
34. Weeks DE, Ott J, Lathrop GM. SLINK: a general simulation program for linkage analysis. Am J Hum Genet. 1990;47(suppl):A204. Abstract.
35. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet. 1996;58:1347-1363.
36. Kong A, Cox NJ. Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet. 1997;61:1179-1188.
37. Cottingham RW Jr, Idury RM, Schaffer AA. Faster sequential genetic linkage computations. Am J Hum Genet. 1993;53:252-263.
38. Lathrop GM, Lalouel JM, White RL. Construction of human linkage maps: likelihood calculations for multilocus linkage analysis. Genet Epidemiol. 1986;3:39-52.
39. Shaffer AA, Gupta SK, Shriram K, Cottingham RW Jr. Avoiding recomputation in linkage analysis. Hum Hered. 1994;44:225-237.
40. Lathrop GM, Lalouel JM, Julier C, Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci U S A. 1984;81:3443-3446.
41. Lathrop GM, Lalouel JM. Easy calculations of LOD scores and genetic risks on small computers. Am J Hum Genet. 1984;36:460-465.
42. Lathrop GM, Lalouel JM, Julier C, Ott J. Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. Am J Hum Genet. 1985;37:482-498.
43. Grayburn PA, Berk MR, Spain MG, Harrison MR, Smith MD, DeMaria AN. Relation of echocardiographic morphology of the mitral apparatus to mitral regurgitation in mitral valve prolapse: assessment by Doppler color flow imaging. Am Heart J. 1990;119:1095-1102.
44. Schwammenthal E, He S, Fontaine AA, Nidorf SM, Vlahakes GJ, Yoganathan AP, Weyman AE, Levine RA. Impact of leaflet geometry on the severity of mitral regurgitation in mitral valve prolapse: insights from an in vitro model. J Am Coll Cardiol. 1994;23:32A. Abstract.
45. Jyo Y, Yoshikawa J, Yoshida K, Kato H, Shakudo M. A new diagnostic criteria of mitral valve prolapse syndrome. J Cardiol Suppl. 1988;18: 29-41.
46. Coonar AS, McKenna WJ. Molecular genetics of familial cardiomyopathies. Adv Genet. 1997;35:285-324.
47. Seidman CE, Seidman JG. Molecular genetic studies of familial hypertrophic cardiomyopathy. Basic Res Cardiol. 1998;93(suppl 3):13-16.
48. Tesson F, Richard P, Charron P, Mathieu B, Cruaud C, Carrier L, Dubourg O, Lautie N, Desnos M, Millaire A, Isnard R, Hagege AA, Bouhour JB, Bennaceur M, Hainque B, Guicheney P, Schwartz K, Komajda M. Genotype-phenotype analysis in four families with mutations in beta-myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy. Hum Mutat. 1998;12:385-392.
49. Durbin AD, Gotlieb AI. Advances towards understanding heart valve response to injury. Cardiovasc Pathol. 2002;11:69-77.
50. Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med. 1994;330:1335-1341.
51. Maslow AD, Regan MM, Haering JM, Johnson RG, Levine RA. Echocardiographic predictors of left ventricular outflow tract obstruction and systolic anterior motion of the mitral valve after mitral valve reconstruction for myxomatous valve disease. J Am Coll Cardiol. 1999;34: 2096-2104.
52. Jebara VA, Dervanian P, Acar C, Grare P, Mihaileanu S, Chauvaud S, Fabiani JN, Deloche A, Carpentier A. Mitral valve repair using Carpentier techniques in patients more than 70 years old: early and late results. Circulation. 1992;86(suppl II)II-53-II-59.
53. Tsukada S, Iwai M, Nishiu J, Itoh M, Tomoike H, Horiuchi M, Nakamura Y, Tanaka T. Inhibition of experimental intimal thickening in mice lacking a novel G-protein-coupIed receptor. Circulation. 2003;107: 313-319.
54. Paine-Saunders S, Viviano BL, Saunders S. GPC6, a novel member of the glypican gene family, encodes a product structurally related to GPC4 and is colocalized with GPC5 on human chromosome 13. Genomics. 1999; 57:455-458.
55. Veugelers M, Vermeesch J, Reekmans G, Steinfeld R, Marynen P, David G. Characterization of glypican-5 and chromosomal localization of human GPC5, a new member of the glypican gene family. Genomics. 1997;40:24-30.
56. Veugelers M, De Cat B, Ceulemans H, Bruystens AM, Coomans C, Durr J, Vermeesch J, Marynen P, David G. Glypican-6, a new member of the glypican family of cell surface heparan sulfate proteoglycans. J Biol Chem. 1999;274:26968-26977.
57. Grande-Allen KJ, Griffin BP, Calabro A, Ratliff NB, Cosgrove DM 3rd, Vesely I. Myxomatous mitral valve chordae, II: selective elevation of glycosaminoglycan content. J Heart Valve Dis. 2001;10:325-332; discussion 332-333.